1 completed, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Achilles Tendinopathy: new trials by email Literature Review of Achilles Tendinopathy trials Research Report on Achilles Tendinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy NGI226, Placebo - Achilles Tendinopathy | Phase 2 | Completed | Novartis Pharmaceuticals | 45 | 2023-06-14 | 2026-09-09 |
| Treatment for Achilles Tendinopathy 25% Dextrose and 1% Lidocaine, Lidocaine, sclerotherapy - Achilles Tendinopathy, Achilles Tendon Enthesopathy | Phase 2 / Phase 3 | Unknown | University of Calgary | 17 | 2007-09-01 | 2009-02-04 |
Neovascularization, Pathologic (1) · Tendinopathy (1)
Metaplasia (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Tendon Injuries (1) · Wounds and Injuries (1)
Glucose (1) · Lidocaine (1) · Sclerotherapy (1)
Novartis Pharmaceuticals (1) · University of Calgary (1)
Canada (1) · France (1) · Germany (1) · United States (1)